Physicians' Academy for Cardiovascular Education

Inflammation & cardiovascular disease: Exploring new options for intervention

July 3, 2013

Presentations of this session will be posted soon


Skopje – Village 5

Monday, September 2, 2013, 12:45 – 13:45 hrs


Educational objectives

  • Review the current evidence supporting the inflammatory hypotheses of atherothrombosis
  • Review the epidemiology of hsCRP in risk stratification in CV disease
  • Discuss the rationale for lowering vascular events by inhibition of inflammation
  • Discuss the mechanism of blocking the pro-inflammatory cytokine interleukin-1β (IL-1β) with a monoclonal antihuman antibody
  • Discuss the potential of current and future strategies targeting inflammation in cardiovascular disease
  • Outline current ongoing clinical development programs aimed to address the inflammation hypothesis in cardiovascular disease


12:45 – 12:50   Introduction
John Kastelein – AMC, Amsterdam, the Netherlands
John Deanfield – UCL, London, United Kingdom

12:50 – 13:05 Inflammation biology in atherosclerosis
Peter Libby – Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

13:05 – 13:20 Biomarkers of inflammation and atherosclerotic risk
Wolfgang Koenig – University of Ulm, Ulm, Germany

13:20 – 13:35 Targeting inflammation in prevention of atherosclerotic events
Paul Ridker – Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

13:35 – 13:45 Q&A & summary
John Kastelein, John Deanfield

Organized and supervized by University College London, Course director; Prof John Deanfield

CME Accreditation

This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for
1 hour of external CME credit(s). Each participant should claim only those hours of credit that have
actually been spent in the educational activity.

EBAC works according to the quality standards the European Accreditation for Continuing Medical
Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).



Acces to this symposium is only for delegates registered for the ESC 2013 congress
To secure a seat at the symposium please pre-register via this link

Download PACE-ESC Inflammation and CV disease symposium invite.pdf


Supported by an unrestricted educational grant from Novartis.
“In compliance with EBAC/ EACCME guidelines, all speakers/Chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

The Organising Committee/ Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.”

Share this page with your colleagues and friends: